Alzheimer's Disease Clinical Trials

Showing 1561-1580 of 1,974 trials

Rivastigmine Capsules in Patients With Probable Vascular Dementia

NCT00130338

The goal of this research study is to evaluate, in the open-label extension phase, the effectiveness, tolerability and safety of rivastigmine capsules in males and females between the ages of 50 and 85 years old with probable vascular dementia.

Vascular Dementia

Novartis521 participantsStarted Feb 2002

COMPLETEDPhase 4

Compliance and Tolerability of Rivastigmine Transdermal Patch 10 cm² in Patients With Probable Alzheimer's Disease.

NCT00731224

This study will evaluate compliance, tolerability, safety, efficacy and caregiver burden of rivastigmine patch 10 cm² treatment in people with Alzheimer's disease (MMSE 10-26) initiating therapy for the first time with a cholinesterase inhibitor, and in patients who were unresponsive to previous cholinesterase inhibitor treatment in a community setting.

Alzheimer's Disease

Novartis Pharmaceuticals380 participantsStarted Jul 2008

East Gosford, New South Wales, Australia • Gosford, New South Wales, Australia • Hornsby, New South Wales, Australia +37 more locations

Rivastigmine Capsules in Patients With Probable Vascular Dementia

Compliance and Tolerability of Rivastigmine Transdermal Patch 10 cm² in Patients With Probable Alzheimer's Disease.

Related Searches

Study Evaluating TheSafety And Efficacy Of PF-05212377 Or Placebo In Subjects With Alzheimer's Disease With Existing Neuropsychiatric Symptoms On Donepezil

18-months Safety Follow-up Study of AADvac1, an Active Tau Vaccine for Alzheimer's Disease

The Efficacy of Butylphthalide Soft Capsules in Patents With VCIND

Open Label Extension Study Evaluating Safety and Tolerability of AAB-003 (PF-05236812) in Subject With Mild to Moderate Alzheimer's Disease

A Plan on Investigation and Collection of Aricept Safety Information With a Dose Increase on Alzheimer's Disease Patients

Apoe Impact Study on Brain Structure and Function, in a Population 45 to 75 Years Old

Comparative Research of Alzheimer's Disease Drugs

Targeted Interdisciplinary Model for Evaluation and Treatment of Neuropscyhiatric Symptoms

Changing Talk to Reduce Resistiveness to Care

Open-label Study of Flexible-dose Paliperidone ER (Extended Release) to Treat Adolescent Schizophrenia.

A Study of the Safety and Tolerability of AZD5213 Effect on Sleep for Patients With Alzheimer's/Cognitive Impairment

The Effect of Movement-oriented Dementia Care on ADL and QoL of Dementia Patients in Nursing Homes

Effect of Cobicistat Versus Ritonavir Boosting on the Brain Permeation of Darunavir in HIV-infected Individuals

The Alzheimer's Disease THErapy With NEuroaid (ATHENE) Study

Impact of Physical Activity on Successful Aging

ABILITY - TelerehABILITation: TechnologY-enhanced Multi-domain at Home Continuum of Care Program

Remote Ischemic Preconditioning for Subcortical Vascular Dementia

"Living Together With Dementia"_Creation and Validation of a Training Program for Family Caregivers of People With Dementia to Live at Home